Interventional cardiology is the branch of cardiology that specifically deals with catheter based treatment of heart diseases, such as congenital heart defect (CHD), coronary artery disease, and aneurysm. This involves insertion of the catheter into femoral artery or any large peripheral artery or vein and through catheter whole procedure is performed by using fluoroscopy. Interventional cardiology has reduced the complications for patients as it provides, fast recovery, short hospital stay, and controlled bleeding.
Furthermore, the device has now received CE Mark, making this the latest version of the company’s first-of-its-kind device approved for use in the European Union. This in turn is also expected to accelerate the growth of the interventional cardiology devices market, especially in North America and Europe.
Global Interventional Cardiology Devices Market: Opportunities
Increasing geriatric population is expected to offer lucrative growth opportunities for players in the global interventional cardiology devices market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.
Read More: https://healthcarepharmaceuticalindustry.blogspot.com/2022/12/interventional-cardiology-devices.html
